Franziska Uhlenbrock

发表

PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade

D. Lardinois, P. Herzig, Marcel P. Trefny, 2020, Cancer Immunology, Immunotherapy.

Lysyl Oxidase Activity Is Required for Ordered Collagen Fibrillogenesis by Tendon Cells*

M. Kjaer, S. Magnusson, K. Kadler, 2015, The Journal of Biological Chemistry.

The NKG2D Ligand ULBP2 Is Specifically Regulated through an Invariant Chain–Dependent Endosomal Pathway

Michael Hagemann-Jensen, S. Pastoreková, L. Andresen, 2014, The Journal of Immunology.

Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform

T. Gjetting, I. Horak, Camilla Fröhlich, 2019, mAbs.

The Selenium Metabolite Methylselenol Regulates the Expression of Ligands That Trigger Immune Activation through the Lymphocyte Receptor NKG2D*

Michael Hagemann-Jensen, L. Ellgaard, L. Andresen, 2014, The Journal of Biological Chemistry.

A conserved WW domain-like motif regulates invariant chain-dependent cell-surface transport of the NKG2D ligand ULBP2.

L. Andresen, S. Skov, F. Uhlenbrock, 2015, Molecular immunology.

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

C. Klein, C. Whitlow, H. Stahlberg, 2019, Science Translational Medicine.

66P Highly exhausted PD-1hi T cell subsets in human NSCLC are co-defined by the predominant expression of distinct inhibitory receptors and correlate with clinical outcome.

D. Thommen, P. Herzig, A. Zippelius, 2016, Journal of Thoracic Oncology.

Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer

C. Klein, K. Mertz, R. Rosenberg, 2020, Journal for ImmunoTherapy of Cancer.

Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptor

C. Klein, M. Bacac, P. Pisa, 2016, Oncoimmunology.

Investigations on the Effect of a Platelet Derived Growth Factor-CC Secreting Breast Carcinoma on Natural Killer Cell Cytotoxicity

F. Uhlenbrock, Franziska Uhlenbrock, 2011 .

A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer

K. Mertz, Z. Trajanoski, Dietmar Rieder, 2019, Clinical Cancer Research.